<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00150553</url>
  </required_header>
  <id_info>
    <org_study_id>SPD417-306</org_study_id>
    <nct_id>NCT00150553</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder</brief_title>
  <official_title>A Phase IIIb, Randomized, Double-Blind, Parallel Group Study in Bipolar I Patients to Assess the Efficacy and Safety of SPD417 Administered Once Daily vs Twice Daily in the Treatment of Manic Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Validus Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Validus Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and safety of SPD417 in treating bipolar
      manic symptoms, when given once daily in the evening vs. twice daily.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date>October 2005</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score on Young Mania Rating Scale (YMRS) at 12 weeks</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to remission</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impressions Scale - Bipolar Version</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HAM-D and MADRS scales for depression</measure>
  </secondary_outcome>
  <enrollment>102</enrollment>
  <condition>Bipolar Disorder</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Extended-release carbamazepine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-IV criteria for bipolar I disorder

          -  Screen YMRS score =&gt; 16

          -  Women of childbearing potential agree to take adequate precautions against
             contraception

        Exclusion Criteria:

          -  Hospitalization required for treatment of psychiatric symptoms

          -  Patients who meet DSM-IV for ultra-rapid cycling

          -  History of serious suicide attempt requiring medical intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>November 1, 2007</last_update_submitted>
  <last_update_submitted_qc>November 1, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carbamazepine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

